ATAI Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-14 | Rao Srinivas | officer: Co-Founder and Chief Scientific Officer | 350,000 | A-Award | A | 350,000 | 0.00 | 0.00 |
| 2023-03-14 | Rao Srinivas | officer: Co-Founder and Chief Scientific Officer | 600,000 | A-Award | A | 600,000 | 1.18 | 708,000.00 |
| 2023-03-14 | Brand Florian | officer: Co-Founder and Chief Executive Officer | 700,000 | A-Award | A | 700,000 | 0.00 | 0.00 |
| 2023-03-14 | Brand Florian | officer: Co-Founder and Chief Executive Officer | 1,600,000 | A-Award | A | 1,600,000 | 1.18 | 1,888,000.00 |
| 2023-03-14 | Kirpekar Sahil | officer: Chief Business Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2023-03-14 | Kirpekar Sahil | officer: Chief Business Officer | 275,000 | A-Award | A | 275,000 | 1.18 | 324,500.00 |
| 2023-03-14 | Gutierrez-Esteinou Rolando | officer: Chief Medical Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2023-03-14 | Gutierrez-Esteinou Rolando | officer: Chief Medical Officer | 500,000 | A-Award | A | 500,000 | 1.18 | 590,000.00 |
| 2023-03-14 | Bardin Stephen | officer: Chief Financial Officer | 350,000 | A-Award | A | 350,000 | 0.00 | 0.00 |
| 2023-03-14 | Bardin Stephen | officer: Chief Financial Officer | 600,000 | A-Award | A | 600,000 | 1.18 | 708,000.00 |
| 2022-12-01 | Kirpekar Sahil | officer: Chief Business Officer | 750,000 | A-Award | A | 750,000 | 3.34 | 2,505,000.00 |
| 2022-05-25 | Smiley Andrea Heslin | director | 64,000 | A-Award | A | 64,000 | 3.84 | 245,760.00 |
| 2022-05-25 | JOHNSON SABRINA MARTUCCI | director | 64,000 | A-Award | A | 64,000 | 3.84 | 245,760.00 |
| 2022-05-25 | de Rosnay Alexis | director | 64,000 | A-Award | A | 64,000 | 3.84 | 245,760.00 |
| 2022-05-25 | Auerbach Michael | director | 64,000 | A-Award | A | 64,000 | 3.84 | 245,760.00 |
| 2022-05-25 | Angermayer Christian | director, 10 percent owner | 64,000 | A-Award | A | 64,000 | 3.84 | 245,760.00 |
| 2022-05-25 | Kalali Amir H | director | 64,000 | A-Award | A | 64,000 | 3.84 | 245,760.00 |
| 2022-04-29 | Apeiron Investment Group Ltd. | 10 percent owner | 1,799,302 | P-Purchase | A | 21,900 | 4.47 | 97,801.02 |
| 2022-04-28 | Apeiron Investment Group Ltd. | 10 percent owner | 1,777,402 | P-Purchase | A | 34,700 | 4.46 | 154,689.13 |
| 2022-04-27 | Apeiron Investment Group Ltd. | 10 percent owner | 1,742,702 | P-Purchase | A | 19,803 | 4.64 | 91,939.39 |
| 2022-04-26 | Apeiron Investment Group Ltd. | 10 percent owner | 1,722,899 | P-Purchase | A | 46,207 | 4.69 | 216,627.66 |
| 2022-04-25 | Apeiron Investment Group Ltd. | 10 percent owner | 1,676,692 | P-Purchase | A | 8,961 | 4.78 | 42,842.54 |
| 2022-04-22 | Apeiron Investment Group Ltd. | 10 percent owner | 1,667,731 | P-Purchase | A | 52,820 | 4.83 | 254,962.14 |
| 2022-04-21 | Apeiron Investment Group Ltd. | 10 percent owner | 1,614,911 | P-Purchase | A | 68,688 | 4.95 | 340,039.94 |
| 2022-04-20 | Apeiron Investment Group Ltd. | 10 percent owner | 1,546,223 | P-Purchase | A | 67,703 | 5.09 | 344,513.49 |
| 2022-04-19 | Apeiron Investment Group Ltd. | 10 percent owner | 1,478,520 | P-Purchase | A | 65,315 | 5.13 | 334,739.38 |
| 2022-04-18 | Apeiron Investment Group Ltd. | 10 percent owner | 1,413,205 | P-Purchase | A | 54,322 | 5.11 | 277,656.04 |
| 2022-04-14 | Apeiron Investment Group Ltd. | 10 percent owner | 1,358,883 | P-Purchase | A | 4,967 | 5.19 | 25,778.73 |
| 2022-04-12 | Apeiron Investment Group Ltd. | 10 percent owner | 1,353,916 | P-Purchase | A | 55,197 | 4.88 | 269,560.07 |
| 2022-04-11 | Apeiron Investment Group Ltd. | 10 percent owner | 1,298,719 | P-Purchase | A | 53,926 | 4.83 | 260,554.25 |
| 2022-04-08 | Apeiron Investment Group Ltd. | 10 percent owner | 1,244,793 | P-Purchase | A | 57,689 | 4.81 | 277,639.85 |
| 2022-04-06 | Apeiron Investment Group Ltd. | 10 percent owner | 1,000,000 | P-Purchase | A | 1,000,000 | 10.10 | 10,103,000.00 |
| 2022-03-02 | Gutierrez-Esteinou Rolando | officer: Chief Medical Officer | 206,950 | A-Award | A | 206,950 | 5.65 | 1,169,267.50 |
| 2022-03-02 | Rao Srinivas | officer: Co-Founder & Chief Scientific Officer | 519,240 | A-Award | A | 519,240 | 5.65 | 2,933,706.00 |
| 2022-03-02 | Rao Srinivas | officer: Co-Founder & Chief Scientific Officer | 840,000 | A-Award | A | 840,000 | 2.44 | 2,049,600.00 |
| 2022-03-02 | Rao Srinivas | officer: Co-Founder & Chief Scientific Officer | 1,307,408 | A-Award | A | 1,307,408 | 2.44 | 3,190,075.52 |
| 2022-03-02 | Brand Florian | officer: Co-Founder & Chief Executive Officer | 649,050 | A-Award | A | 649,050 | 5.65 | 3,667,132.50 |
| 2022-03-02 | WEAVER GREGORY L | officer: Chief Financial Officer | 228,000 | A-Award | A | 228,000 | 5.65 | 1,288,200.00 |
| 2022-01-14 | Auerbach Michael | director | 0 | J-Other | D | 5,559,808 | 0.00 | 0.00 |
| 2021-12-24 | Gutierrez-Esteinou Rolando | officer: Chief Medical Officer | 0 | A-Award | A | 0 | 0.00 | 0.00 |
| 2021-12-24 | Gutierrez-Esteinou Rolando | officer: Chief Medical Officer | 325,000 | A-Award | A | 325,000 | 7.72 | 2,509,000.00 |
| 2021-09-10 | Camm Jason | director | 128,000 | A-Award | A | 128,000 | 16.46 | 2,106,880.00 |
| 2021-09-10 | JOHNSON SABRINA MARTUCCI | director | 128,000 | A-Award | A | 128,000 | 16.46 | 2,106,880.00 |
| 2021-09-10 | Auerbach Michael | director | 128,000 | A-Award | A | 128,000 | 16.46 | 2,106,880.00 |
| 2021-09-10 | de Rosnay Alexis | director | 128,000 | A-Award | A | 128,000 | 16.46 | 2,106,880.00 |
| 2021-09-10 | Angermayer Christian | director, 10 percent owner | 128,000 | A-Award | A | 128,000 | 16.46 | 2,106,880.00 |
| 2021-09-10 | Smiley Andrea Heslin | director | 128,000 | A-Award | A | 128,000 | 16.46 | 2,106,880.00 |
| 2021-09-10 | Kalali Amir H | director | 128,000 | A-Award | A | 128,000 | 16.46 | 2,106,880.00 |
| 2021-06-22 | Angermayer Christian | director, 10 percent owner | 20,185,200 | P-Purchase | A | 700,000 | 15.00 | 10,500,000.00 |
| 2021-06-22 | Angermayer Christian | director, 10 percent owner | 20,185,200 | - | A | 700,000 | 15.00 | 10,500,000.00 |
| 2021-06-22 | Kalali Amir H | director | 4,666 | P-Purchase | A | 4,666 | 15.00 | 69,990.00 |
| 2021-06-22 | Auerbach Michael | director | 5,564,474 | P-Purchase | A | 4,666 | 15.00 | 69,990.00 |
| 2021-06-22 | WEAVER GREGORY L | officer: Chief Financial Officer | 4,666 | P-Purchase | A | 4,666 | 15.00 | 69,990.00 |
| 2021-06-22 | Rao Srinivas | officer: See Remarks | 3,500 | P-Purchase | A | 3,500 | 15.00 | 52,500.00 |
| 2021-06-22 | Apeiron Investment Group Ltd. | 10 percent owner | 20,185,200 | - | A | 700,000 | 15.00 | 10,500,000.00 |
| 2021-06-22 | Apeiron Investment Group Ltd. | 10 percent owner | 20,185,200 | P-Purchase | A | 700,000 | 15.00 | 10,500,000.00 |
| 2021-06-22 | Smiley Andrea Heslin | director | 4,666 | P-Purchase | A | 4,666 | 15.00 | 69,990.00 |
| 2021-06-22 | de Rosnay Alexis | director | 4,666 | P-Purchase | A | 4,666 | 15.00 | 69,990.00 |
| 2021-06-22 | Brand Florian | officer: See Remarks | 2,333 | P-Purchase | A | 2,333 | 15.00 | 34,995.00 |
| 2021-06-17 | Gutierrez-Esteinou Rolando | officer: Chief Medical Officer | 752,311 | A-Award | A | 752,311 | 15.00 | 11,284,665.00 |
| 2021-06-17 | WEAVER GREGORY L | officer: Chief Financial Officer | 67,726 | A-Award | A | 67,726 | 15.00 | 1,015,890.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.